Thymosthenic agents, a novel approach in the treatment of schizophrenia.
Gelders
Y G
YG
Clinical R & D Department Psychiatry, Janssen Research Foundation, Beerse.
D001921:Brain / Q000187:drug effects; D002090:Butyrophenones / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011985:Receptors, Serotonin / Q000187:drug effects; D018967:Risperidone; D016713:Ritanserin; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D002090:Butyrophenones; D007555:Isoxazoles; D010880:Piperidines; D011744:Pyrimidinones; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D016713:Ritanserin; C005569:pipamperone; C045359:setoperone; D018967:Risperidone